These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 1369122)
61. Applications of antisense oligonucleotides in oncology. Pierga JY; Magdelenat H Cell Mol Biol (Noisy-le-grand); 1994 May; 40(3):237-61. PubMed ID: 7920172 [TBL] [Abstract][Full Text] [Related]
62. [Recent progress and prospect in oligonucleotide therapeutics]. Yoshioka K; Kuwahara H; Nishina K; Nagata T; Yokota T Nihon Rinsho; 2015 Jun; 73(6):1057-65. PubMed ID: 26065142 [TBL] [Abstract][Full Text] [Related]
63. Antisense therapy for cancer. Gleave ME; Monia BP Nat Rev Cancer; 2005 Jun; 5(6):468-79. PubMed ID: 15905854 [TBL] [Abstract][Full Text] [Related]
64. Nucleic acid-based drugs against emerging zoonotic viruses. Wong JP Future Med Chem; 2015; 7(13):1709-19. PubMed ID: 26399689 [TBL] [Abstract][Full Text] [Related]
65. Inhibition of human cytomegalovirus replication in a human retinal epithelial cell model by antisense oligonucleotides. Detrick B; Nagineni CN; Grillone LR; Anderson KP; Henry SP; Hooks JJ Invest Ophthalmol Vis Sci; 2001 Jan; 42(1):163-9. PubMed ID: 11133862 [TBL] [Abstract][Full Text] [Related]
66. Potential therapeutic application of antisense oligonucleotides in the treatment of ocular diseases. Danis RP; Henry SP; Ciulla TA Expert Opin Pharmacother; 2001 Feb; 2(2):277-91. PubMed ID: 11336586 [TBL] [Abstract][Full Text] [Related]
67. Progress in antisense therapeutics discovery and development. Crooke ST Ciba Found Symp; 1997; 209():158-64; discussion 164-8. PubMed ID: 9383575 [TBL] [Abstract][Full Text] [Related]
68. Antisense therapeutics: from theory to clinical practice. Pirollo KF; Rait A; Sleer LS; Chang EH Pharmacol Ther; 2003 Jul; 99(1):55-77. PubMed ID: 12804699 [TBL] [Abstract][Full Text] [Related]
70. An overview of sugar-modified oligonucleotides for antisense therapeutics. Prakash TP Chem Biodivers; 2011 Sep; 8(9):1616-41. PubMed ID: 21922654 [TBL] [Abstract][Full Text] [Related]
71. Antisense oligonucleotide inhibitors for the treatment of cancer: 1. Pharmacokinetic properties of phosphorothioate oligodeoxynucleotides. Geary RS; Leeds JM; Henry SP; Monteith DK; Levin AA Anticancer Drug Des; 1997 Jul; 12(5):383-93. PubMed ID: 9236854 [No Abstract] [Full Text] [Related]
72. Drug evaluation: ISIS-301012, an antisense oligonucleotide for the treatment of hypercholesterolemia. Burnett JR Curr Opin Mol Ther; 2006 Oct; 8(5):461-7. PubMed ID: 17078389 [TBL] [Abstract][Full Text] [Related]
79. First antisense drug trials planned in leukemia. Reynolds T J Natl Cancer Inst; 1992 Mar; 84(5):288-90. PubMed ID: 1738177 [No Abstract] [Full Text] [Related]